Zhen Cai is a Senior Scientist with extensive experience in cancer biology and drug development. They earned a Ph.D. in Biochemistry and Molecular Biology from the Shanghai Institutes for Biological Sciences and completed postdoctoral training at MD Anderson Cancer Center. Following a tenure as an instructor and then assistant professor at Wake Forest University, Zhen transitioned to the pharmaceutical industry and joined Zentalis Pharmaceuticals in 2021, where they focus on target validation and synthetic lethality strategies in cancer treatment. Zhen has published numerous papers in high-impact journals, contributing significantly to the fields of signal transduction and cancer metabolism.
This person is not in the org chart
This person is not in any teams
This person is not in any offices